T. Rowe Price Associates’s Aligos Therapeutics ALGS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-903	Closed	-$49K	–	2952
2022 Q1	$49K	Buy	903 +20	+2%	+$1.09K	﹤0.01%	2915
2021 Q4	$262K	Sell	883 -208	-19%	-$61.7K	﹤0.01%	2650
2021 Q3	$423K	Buy	1,091 +2	+0.2%	+$775	﹤0.01%	2444
2021 Q2	$555K	Buy	+1,089	New	+$555K	﹤0.01%	2334